CUSIP: 05070R104
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,421,847
-
Share change
-
+15,421,847
-
Total reported value
-
$272,037,347
-
Price per share
-
$17.81
-
Number of holders
-
49
-
Value change
-
+$272,037,347
-
Number of buys
-
49
Quarterly Holders Quick Answers
What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05070R104:
Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q3 2016
As of 30 Sep 2016,
AUDENTES THERAPEUTICS INC - COM (BOLD) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,421,847 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Versant Venture Management, LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, RA CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., Rock Springs Capital Management LP, VHCP Management II, LLC, and Cormorant Asset Management, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.